Navigation Links
BioMed Central welcomes the new National Institutes of Health public access policy

Yet another follow up of the NIH public access policy announced earlier this week, this time from free-access publisher BioMed Central :

BioMed Central welcomes the announcement of the US National Institutes of Health (NIH) new public access policy. The NIH calls on all of its grantees to deposit articles resulting from their NIH-funded research in the National Library of Medicine's PubMed Central and make them freely available within 12 months.

BioMed Central anticipates that many other funding bodies worldwide will now follow the example set by NIH.

All NIH grantees now have a new factor to take into account when choosing where they wish to publish their research. To fulfil the NIH request, authors publishing with most of the traditional subscription publishers will be expected to go through a process of resubmitting their papers to the PubMed Central repository. In addition, they will often need to update their manuscript version with the changes introduced in the publication process, as many publishers specify that only the author's version of the manuscript can be submitted to archives.

Those who choose to publish in any of BioMed Central's Open Access journals, which cover all areas of biology and medicine, are assured that the published version of their paper will be placed in PubMed Central for them, immediately and without any need for additional work from them. Researchers are thus saved the time and effort of going through the deposition process themselves.

This significant benefit is in addition to the rapid and high quality peer review, fast publication and high visibility of BioMed Central's Open Access journals.

BioMed Central urges all researchers in the life and medical sciences to fulfil the NIH request and to submit their future manuscripts to one of the 130 Open Access journals publishe d by BioMed Central.


Source:BioMed Central

Related biology news :

1. BioMed Central launches Biology Direct
2. Impressive new Impact Factors for BioMed Centrals open-access journals
3. Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis
4. Parts of the Caribbean and Central America are likely to have less summer rain
5. Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site
6. National Academies advisory: Invasive aquatic species in the Great Lakes
7. Virginia Bioinformatics Institutes launches microbial database
8. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
9. Health costs soar as 60 million Americans classed as obese
10. Going To Extremes To Improve Human Health
11. Patient-choice C-section rate rises 36%: HealthGrades study
Post Your Comments:

(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/9/2015)... Nov. 09, 2015 ... of the "Global Law Enforcement Biometrics ... --> ) has announced ... Enforcement Biometrics Market 2015-2019" report to ... Markets ( ) has announced the ...
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... CHESTERFIELD, United Kingdom , Nov. 27, 2015 /PRNewswire/--  ... specialty biopharmaceutical company, announced today that it has closed ... systems (CMDS) business to Guerbet (GBT- NYSE Euronext) in ... CMDS operations encompassed four manufacturing facilities and a total ... nearly 75 in the St. Louis ...
(Date:11/27/2015)... 27, 2015 ... of companion diagnostics is one of the ... with pharmaceutical companies and diagnostic manufacturers working ... . --> ... on global cancer biomarkers market spread across ...
(Date:11/26/2015)... , November 26, 2015 --> ... company specializing in imaging technologies, announced today that it has ... part of the Horizon 2020 European Union Framework Programme for ... large-scale clinical trial in breast cancer. , ... --> --> The study ...
(Date:11/25/2015)...  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that ... plan (Rights Plan) in an effort to preserve the ... Section 382 of the Internal Revenue Code (Code). ... of its NOLs could be substantially limited if the ... 382 of the Code. In general, an ownership change ...
Breaking Biology Technology: